Lisa Benincosa, PhD
SVP,
Clinical Pharmacology Strategy
Neurological clinical trials face a range of unique challenges due to the complexity of the peripheral and central nervous systems, the intricate nature of neurological diseases, and the complexity of measuring neurological and psychiatric outcomes. Memory and other cognitive impairments, behavioural abnormalities, reduced motor capability, and sensory deficiencies, all create a high burden on patients as well as the caregivers on whom many are dependent.
For more than 30 years, Allucent has been at the forefront of neuroscience clinical development projects worldwide, involving over 140 clinical trials in more than 40 indications, bringing hope and breakthrough treatments to countless patients suffering from neurological disorders.
Neurological clinical development requires the specialized services and solutions of a neuroscience CRO to ensure a comprehensive regulatory strategy, a robust study design, effective patient-focused recruitment strategies, and industry-leading technology solutions.
ACE: Neuroscience and Psychiatry offers cross-functional expertise through clinical pharmacology experts, regulatory strategists, biostatistical consultants, medical affairs, and operational experts, who share your deep commitment to developing therapies for neurodegenerative, neurological, rare neurological, pain, and psychiatric conditions.
Click icons for more information:
Allucent has conducted a wide range of neuroscience clinical trials, from early phase trials where dose escalation was dependent on repeated CSF sampling and neuroimaging, to worldwide Phase III trials with various interim analyses or adaptive designs.
140+
Studies
1,950+
Sites
15,450+
Patients
680+
Consulting Projects
All-time years of experience
With global breadth and depth across a wide range of neuroscience & psychiatric indications, Allucent partners with biotech companies to bring innovative therapies to light.
Blog
Learn More
Webinar
Learn More
Blog
Learn More
Publication
Learn More
Let us know how we can help you bring new therapies to light. Get in touch to get started.
Want to help small and mid-sized biotech companies change the therapeutic landscape?